Bone health in neuroendocrine tumors and prognostic implications beyond skeletal metastases - Top-Institutions - MDSpire

Bone health in neuroendocrine tumors and prognostic implications beyond skeletal metastases

  • By

  • Andrea Casabella

  • Iderina Hasballa

  • Anna Arecco

  • Mara Boschetti

  • Leonardo Della Sala

  • Davide Demontis

  • Alberto Sulli

  • Lara Vera

  • Alessandro Veresani

  • Diego Ferone

  • Sabrina Paolino

  • Manuela Albertelli

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    IRCCS Policlinico San Martino
    IRCCS Policlinico San Martino

    Genoa, Italy

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    University of Toronto
    University of Toronto

    Toronto, Ontario

    Key Differentiators

    • Oncology

  • #4

    Fred & Pamela Buffett Cancer Center
    Fred & Pamela Buffett Cancer Center

    Omaha, Nebraska

    Key Differentiators

    • Oncology

Original Source(s)

Bone health in neuroendocrine tumors and prognostic implications beyond skeletal metastases

  • by Andrea Casabella, Iderina Hasballa, Anna Arecco, Mara Boschetti, Leonardo Della Sala, Davide Demontis, Alberto Sulli, Lara Vera, Alessandro Veresani, Diego Ferone, Sabrina Paolino, Manuela Albertelli

  • July 1, 2026

Related Content

Impact of RAS mutation status on early progression in patients with initially unresectable colorectal liver metastases undergoing conversion therapy: a retrospective analysis

Hypoxia-driven tumor immune escape: mechanisms and therapeutic opportunities

The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics